Market was valued at USD 472.77 Million in 2024 and is expected to reach USD 728.10 Million by 2030, growing at a CAGR of 7.42% during the forecast period. The market is being driven by the increasing ...
The Vietnam Pharmaceuticals Market was valued at USD 7.60 billion in 2024 and is projected to reach USD 12.12 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.96% during the ...
EuroCham Vietnam engaged in high-level discussions with Prime Minister Pham Minh Chinh on Sunday 2 March 2025, addressing key ...
Such groups include AstraZeneca Vietnam, which has committed to investing approximately $220 million in the country over the ...
Nguyễn Lan Hương from Sanofi Vietnam JSC emphasised the need to review regulations on managing drug imports, without a circulation registration certificate in Việt Nam. Hương suggested that drugs ...
Sanofi’s Sarclisa has received approval in more than 50 nations and regions. Credit: LCV/Shutterstock. Sanofi’s Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and ...
In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...
It is one of just two dengue vaccines approved by the WHO, the other one being Sanofi-Pasteur’s Dengvaxia, which became mired in controversy in the Philippines and caused strong vaccine ...
HANOI: Vietnam's parliament on Wednesday (Feb 19) approved plans for an US$8 billion rail link from its largest northern port city to the border with China, boosting links between the two ...
Image credit: Shutterstock / Leitenberger Photography. Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement ...
We examine Vietnam’s new Value Added Tax (VAT) Law, set to take effect on July 1, 2025, which introduces significant changes to the country’s VAT regime. Recent clarifications are outlined in Official ...